These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9652571)

  • 1. Monitoring compliance with antituberculous treatment by detection of isoniazid in urine.
    Elizaga J; Friedland JS
    Lancet; 1997 Oct; 350(9086):1225-6. PubMed ID: 9652571
    [No Abstract]   [Full Text] [Related]  

  • 2. Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
    Palanduz A; Gültekin D; Erdem E; Kayaalp N
    Ann Trop Paediatr; 2003 Mar; 23(1):47-50. PubMed ID: 12648324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine color testing and isoniazid monitoring.
    Cope GF; Whitfield R
    Chest; 2003 Dec; 124(6):2405; author reply 2405. PubMed ID: 14665533
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
    Meissner PE; Musoke P; Okwera A; Bunn JE; Coulter JB
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):903-8. PubMed ID: 12365577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care urine test for assessing adherence to isoniazid treatment for tuberculosis.
    Soobratty MR; Whitfield R; Subramaniam K; Grove G; Carver A; O'Donovan GV; Wu HH; Lee OY; Swaminathan R; Cope GF; Milburn HJ
    Eur Respir J; 2014 May; 43(5):1519-22. PubMed ID: 24435008
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of compliance with antituberculous chemoprophylaxis among recluse population of the Jaen penitentiary center].
    Romero Saldaña M; Vaquero Abellán M; Gallego Rubio R; Aguilera López MD; de Celis Cornejo JM; Barquín García E; Zurita Serrano R
    Rev Esp Salud Publica; 1997; 71(4):391-9. PubMed ID: 9490193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine color test to monitor isoniazid compliance: "pissin' in the wind"?
    Hollender ES; Ashkin D; Narita M
    Chest; 2003 Mar; 123(3):668-70. PubMed ID: 12628857
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the Arkansas method of urine testing for isoniazid in South Africa.
    Hanifa Y; Mngadi K; Lewis J; Fielding K; Churchyard G; Grant AD
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1232-6. PubMed ID: 17958987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.
    Manders AJ; Banerjee A; van den Borne HW; Harries AD; Kok GJ; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):838-42. PubMed ID: 11573895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of tuberculosis.
    Meissner PE; Coulter JB
    N Engl J Med; 2001 Nov; 345(20):1502. PubMed ID: 11794211
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection.
    Eidlitz-Markus T; Zeharia A; Baum G; Mimouni M; Amir J
    Chest; 2003 Mar; 123(3):736-9. PubMed ID: 12628871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine testing to monitor adherence to TB preventive therapy.
    Perry S; Hovell MF; Blumberg E; Berg J; Vera A; Sipan C; Kelley N; Moser K; Catanzaro A; Friedman L
    J Clin Epidemiol; 2002 Mar; 55(3):235-8. PubMed ID: 11864793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modified method for indicating antitubercular agents in the urine in tuberculosis].
    Solov'eva AS; Lukomskaia VM
    Lab Delo; 1980; (12):756-7. PubMed ID: 6163900
    [No Abstract]   [Full Text] [Related]  

  • 14. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
    Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
    BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.
    Fallab-Stubi CL; Zellweger JP; Sauty A; Uldry C; Iorillo D; Burnier M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):525-30. PubMed ID: 9661817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating tuberculosis with one combination drug.
    Macnab MF; Seager JR
    S Afr Med J; 1994 Aug; 84(8 Pt 1):507-8. PubMed ID: 7825089
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting.
    MacIntyre CR; Goebel K; Brown GV; Skull S; Starr M; Fullinfaw RO
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):848-54. PubMed ID: 12971668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
    Duarte R; Carvalho A; Correia A
    Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laboratory monitoring by urine analysis of pulmonary tuberculosis patient compliance in taking 2d series preparations and isoniazid derivatives].
    Radkevich RA; Utkin VV; Guseva TM
    Lab Delo; 1978; (2):84-6. PubMed ID: 76009
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of pulmonary tuberculosis. Current options.
    Addington WW
    Arch Intern Med; 1979 Dec; 139(12):1391-5. PubMed ID: 518222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.